Liraglutide Clinical Trials
6 recruitingDrug
Phase 43Phase 12Phase 22
Showing 1–6 of 6 trials
Recruiting
Phase 1
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Obesity
Novo Nordisk A/S75 enrolled1 locationNCT07225816
Recruiting
Phase 2
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Maturity Onset Diabetes of the Young
Mansa50 enrolled1 locationNCT07029009
Recruiting
Phase 4
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
Metabolic Syndrome
University of Virginia80 enrolled1 locationNCT04575844
Recruiting
Phase 1Phase 2
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Diabete Type 2
Biolingus15 enrolled1 locationNCT05268237
Recruiting
Phase 4
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Overweight and ObesityHyperglycaemia (Diabetic)Type 2 Diabetes Patients
The First Affiliated Hospital of Xiamen University164 enrolled1 locationNCT03087032
Recruiting
Phase 4
LIROH - Liraglutide for Obesity in HIV
ObesityHIV Infections
Brigham and Women's Hospital40 enrolled1 locationNCT06438146